CellMiner Cross-Database (CellMinerCDB) version 1.2: Exploration of patient-derived cancer cell line pharmacogenomics
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CellMiner Cross-Database (CellMinerCDB) version 1.2: Exploration of patient-derived cancer cell line pharmacogenomics
Authors
Keywords
-
Journal
NUCLEIC ACIDS RESEARCH
Volume 49, Issue D1, Pages D1083-D1093
Publisher
Oxford University Press (OUP)
Online
2020-10-20
DOI
10.1093/nar/gkaa968
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Quantitative Proteomics of the Cancer Cell Line Encyclopedia
- (2020) David P. Nusinow et al. CELL
- SYNERGxDB: an integrative pharmacogenomic portal to identify synergistic drug combinations for precision oncology
- (2020) Heewon Seo et al. NUCLEIC ACIDS RESEARCH
- BAP1 is a haploinsufficient tumor suppressor linking chronic pancreatitis to pancreatic cancer in mice
- (2020) Stephanie Perkail et al. Nature Communications
- Epigenome-wide DNA methylation analysis of small cell lung cancer cell lines suggests potential chemotherapy targets
- (2020) Julia Krushkal et al. Clinical Epigenetics
- Interleukin-6 derived from cancer-associated fibroblasts attenuates the p53 response to doxorubicin in prostate cancer cells
- (2020) Emarndeena H. Cheteh et al. Cell Death Discovery
- SCLC-CellMiner: A Resource for Small Cell Lung Cancer Cell Line Genomics and Pharmacology Based on Genomic Signatures
- (2020) Camille Tlemsani et al. Cell Reports
- RNA sequencing of the NCI-60: Integration into CellMiner and CellMiner CDB
- (2019) William C. Reinhold et al. CANCER RESEARCH
- Next-generation characterization of the Cancer Cell Line Encyclopedia
- (2019) Mahmoud Ghandi et al. NATURE
- The landscape of cancer cell line metabolism
- (2019) Haoxin Li et al. NATURE MEDICINE
- DrugComb: an integrative cancer drug combination data portal
- (2019) Bulat Zagidullin et al. NUCLEIC ACIDS RESEARCH
- Schlafen 11 (SLFN11), a restriction factor for replicative stress induced by DNA-targeting anti-cancer therapies
- (2019) Junko Murai et al. PHARMACOLOGY & THERAPEUTICS
- Predicting Synergism of Cancer Drug Combinations Using NCI-ALMANAC Data
- (2019) Pavel Sidorov et al. Frontiers in Chemistry
- Frequent Loss of IRF2 in Cancers Leads to Immune Evasion through Decreased MHC Class I Antigen Presentation and Increased PD-L1 Expression
- (2019) Barry A. Kriegsman et al. JOURNAL OF IMMUNOLOGY
- Integration of Bioinformatics Resources Reveals the Therapeutic Benefits of Gemcitabine and Cell Cycle Intervention in SMAD4-Deleted Pancreatic Ductal Adenocarcinoma
- (2019) Yao-Yu Hsieh et al. Genes
- Antigen presentation and tumor immunogenicity in cancer immunotherapy response prediction
- (2019) Shixiang Wang et al. eLife
- Oncogenic Signaling Pathways in The Cancer Genome Atlas
- (2018) Francisco Sanchez-Vega et al. CELL
- GDA, a web-based tool for Genomics and Drugs integrated analysis
- (2018) Jimmy Caroli et al. NUCLEIC ACIDS RESEARCH
- Genetic and transcriptional evolution alters cancer cell line drug response
- (2018) Uri Ben-David et al. NATURE
- SMARCD2 subunit of SWI/SNF chromatin-remodeling complexes mediates granulopoiesis through a CEBPɛ dependent mechanism
- (2017) Pierre Priam et al. NATURE GENETICS
- Computational correction of copy number effect improves specificity of CRISPR–Cas9 essentiality screens in cancer cells
- (2017) Robin M Meyers et al. NATURE GENETICS
- PharmacoDB: an integrative database for mining in vitro anticancer drug screening studies
- (2017) Petr Smirnov et al. NUCLEIC ACIDS RESEARCH
- Compromised BRCA1–PALB2 interaction is associated with breast cancer risk
- (2017) T K Foo et al. ONCOGENE
- Phosphorylated fraction of H2AX as a measurement for DNA damage in cancer cells and potential applications of a novel assay
- (2017) Jiuping Ji et al. PLoS One
- The NCI-60 Methylome and Its Integration into CellMiner
- (2016) William C. Reinhold et al. CANCER RESEARCH
- A Landscape of Pharmacogenomic Interactions in Cancer
- (2016) Francesco Iorio et al. CELL
- Small Cell Lung Cancer Screen of Oncology Drugs, Investigational Agents, and Gene and microRNA Expression
- (2016) Eric Polley et al. JNCI-Journal of the National Cancer Institute
- Small Cell Lung Cancer Screen of Oncology Drugs, Investigational Agents, and Gene and microRNA Expression
- (2016) Eric Polley et al. JNCI-Journal of the National Cancer Institute
- PharmacoGx: an R package for analysis of large pharmacogenomic datasets
- (2015) Petr Smirnov et al. BIOINFORMATICS
- rcellminer: exploring molecular profiles and drug response of the NCI-60 cell lines in R
- (2015) Augustin Luna et al. BIOINFORMATICS
- Using CellMiner 1.6 for Systems Pharmacology and Genomic Analysis of the NCI-60
- (2015) W. C. Reinhold et al. CLINICAL CANCER RESEARCH
- FACT Proteins, SUPT16H and SSRP1, Are Transcriptional Suppressors of HIV-1 and HTLV-1 That Facilitate Viral Latency
- (2015) Huachao Huang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Pharmacogenomic agreement between two cancer cell line data sets
- (2015) Nicolas Stransky et al. NATURE
- Correlating chemical sensitivity and basal gene expression reveals mechanism of action
- (2015) Matthew G Rees et al. Nature Chemical Biology
- PubChem Substance and Compound databases
- (2015) Sunghwan Kim et al. NUCLEIC ACIDS RESEARCH
- High Resolution Copy Number Variation Data in the NCI-60 Cancer Cell Lines from Whole Genome Microarrays Accessible through CellMiner
- (2014) Sudhir Varma et al. PLoS One
- Gene Expression Correlations in Human Cancer Cell Lines Define Molecular Interaction Networks for Epithelial Phenotype
- (2014) Kurt W. Kohn et al. PLoS One
- NCI-60 Whole Exome Sequencing and Pharmacological CellMiner Analyses
- (2014) William C. Reinhold et al. PLoS One
- Parallel genome-scale loss of function screens in 216 cancer cell lines for the identification of context-specific genetic dependencies
- (2014) Glenn S Cowley et al. Scientific Data
- The Exomes of the NCI-60 Panel: A Genomic Resource for Cancer Biology and Systems Pharmacology
- (2013) O. D. Abaan et al. CANCER RESEARCH
- Inconsistency in large pharmacogenomic studies
- (2013) Benjamin Haibe-Kains et al. NATURE
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- CellMiner: A Web-Based Suite of Genomic and Pharmacologic Tools to Explore Transcript and Drug Patterns in the NCI-60 Cell Line Set
- (2012) W. C. Reinhold et al. CANCER RESEARCH
- Vemurafenib (RG67204, PLX4032): a potent, selective BRAF kinase inhibitor
- (2012) Samit Patrawala et al. Future Oncology
- Systematic identification of genomic markers of drug sensitivity in cancer cells
- (2012) Mathew J. Garnett et al. NATURE
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
- (2012) Jordi Barretina et al. NATURE
- Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells
- (2012) Wanjuan Yang et al. NUCLEIC ACIDS RESEARCH
- Putative DNA/RNA helicase Schlafen-11 (SLFN11) sensitizes cancer cells to DNA-damaging agents
- (2012) G. Zoppoli et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Exon Array Analyses across the NCI-60 Reveal Potential Regulation of TOP1 by Transcription Pausing at Guanosine Quartets in the First Intron
- (2010) W. C. Reinhold et al. CANCER RESEARCH
- mRNA and microRNA Expression Profiles of the NCI-60 Integrated with Drug Activities
- (2010) H. Liu et al. MOLECULAR CANCER THERAPEUTICS
- Genome-Wide mRNA and microRNA Profiling of the NCI 60 Cell-Line Screen and Comparison of FdUMP[10] with Fluorouracil, Floxuridine, and Topoisomerase 1 Poisons
- (2010) W. H. Gmeiner et al. MOLECULAR CANCER THERAPEUTICS
- Multifactorial Regulation of E-Cadherin Expression: An Integrative Study
- (2010) W. C. Reinhold et al. MOLECULAR CANCER THERAPEUTICS
- CancerResource: a comprehensive database of cancer-relevant proteins and compound interactions supported by experimental knowledge
- (2010) Jessica Ahmed et al. NUCLEIC ACIDS RESEARCH
- Regulation of the apoptosis-inducing kinase DRAK2 by cyclooxygenase-2 in colorectal cancer
- (2009) G A Doherty et al. BRITISH JOURNAL OF CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search